|
|
||||||||
Clinical Chemistry, Vol 38, 416-420, Copyright © 1992 by American Association for Clinical Chemistry
V Kairisto, P Koskinen, K Mattila, J Puikkonen, A Virtanen, I Kantola and K Irjala
Central Laboratory, University Central Hospital of Turku, Finland.
The urinary excretion of normetanephrine, metanephrine, and 3-methoxy-4- hydroxymandelic acid was quantified by HPLC in hypertensive patients who were being routinely investigated for the exclusion of pheochromocytoma. The data were used to calculate reference intervals for these analytes. Age- and sex-specific 95% reference intervals for 24-h urinary excretion were as follows (mumol/24 h): normetanephrine in men ages 16-35 years (n = 17) 0.7-3.4, in men older than 35 years (n = 121) 0.8-5.1, in women ages 16-35 years (n = 41) 0.5-2.1, and in women older than 35 years (n = 144) 0.6-3.3 mumol/24 h; metanephrine in men (n = 138) 0.3-2.0, and in women (n = 185) 0.2-1.3; and 3-methoxy-4- hydroxymandelic acid in men (n = 142) 10-54, and in women (n = 184) 9- 38. Normetanephrine or metanephrine excretion rates or both exceeded the proposed reference intervals in seven of the eight patients with pheochromocytoma. Determination of 3-methoxy-4-hydroxymandelic acid excretion did not yield any additional diagnostic information.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |